Founder, President and CEO
Reviva Pharmaceuticals Holdings Inc
Laxminarayan Bhat, PhD, is the Founder, President, and Chief Executive Officer of Reviva Pharmaceuticals. Dr. Bhat founded Reviva in 2006 and since its inception, the company has advanced under his leadership with a portfolio of propriety compounds at different stages in a pipeline encompassing central nervous system (CNS), cardiometabolic, and immune disorders. Dr. Bhat has over 25 years of experience in translational research and development in pharmaceutical industry, and prior to founding Reviva, he held research positions at XenoPort, ARYx Therapeutics, and Higuchi Biosciences Center in the United States. Dr. Bhat conducted extensive graduate and post-graduate training in medicinal chemistry in India, France, Germany, and USA. Dr. Bhat has published over 25 research papers in peer reviewed international journals and has given several invited lectures/presentations in national and international conferences. Dr. Bhat is an inventor on over 100 granted patents and contributed to multiple investigational new drugs (IND) and a US FDA approved new drug currently in the market worldwide.